Methods for the Measurement of Platelet Function - 12/08/11
Address for reprints: Alan D. Michelson, MD, Center for Platelet Function Studies, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, Massachusetts 01655Résumé |
This article discusses the advantages and disadvantages of methods for the measurement of platelet function. The focus is on tests that can be used to monitor antiplatelet activity in the setting of cardiovascular disease and potentially predict thrombosis and bleeding. The tests described are platelet aggregometry; impedance aggregometry; VerifyNow (Accumetrics, San Diego, CA); Plateletworks (Helena Laboratories, Beaumont, TX); platelet surface P-selectin, platelet surface–activated glycoprotein IIb/IIIa, and leukocyte–platelet aggregates; TEG Platelet Mapping system (Haemoscope, Niles, IL); Impact cone and plate(let) analyzer (DiaMed, Cressier, Switzerland); Platelet Function Analyzer-100 (Siemens Healthcare Diagnostics, Inc., Deerfield, IL); phosphorylation of vasodilator-stimulated phosphoprotein; serum thromboxane B2; and urinary 11-dehydro thromboxane B2. Some of the factors that differentiate these tests are sample volume requirements, the use of whole blood, the presence of shear, point-of-care status, need for a technician, and expense.
Le texte complet de cet article est disponible en PDF.Plan
| Statement of author disclosure: Please see the Author Disclosures section at the end of this article. |
Vol 103 - N° 3S
P. 20A-26A - février 2009 Retour au numéro
Article précédent
- Role of Antiplatelet Therapy Across the Spectrum of Patients with Coronary Artery Disease
- Deepak L. Bhatt
- Variability in Responsiveness to Oral Antiplatelet Therapy
- Dominick J. Angiolillo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?